โšกToday
โœจToday's leadDoctors Complete First Bone Marrow Transplant From Deceased Donor for Non-Malignant Disease๐ŸŽˆFor kidsSouth Carolina tract beside wildlife refuge to be permanently conserved๐ŸŒฟNatureFormer ocean liner S.S. United States becomes the world's largest artificial reefโšฝSportsLindy Duncan wins her first LPGA title on attempt 222๐ŸŽจCulture & ideasA Lost Altdorfer Landscape Surfaces After 70 Years Privately Held๐Ÿ”ฌScience & healthPeople who control HIV without treatment may help find a cure๐Ÿ’›KindnessA laid-off man began mowing lawns for free and 2,100 volunteers joined๐Ÿ›๏ธPoliticsLos Angeles bans oil drilling after a decade of neighborhood pressure๐Ÿš€ProgressPhiladelphia repaired a collapsed interstate in 12 days

Engineered immune cells clear deadly childhood brain tumors in mice

ScienceDaily 8 November 2026 2 min read

โฎ BeforeChildren with diffuse midline glioma have an almost always fatal prognosis within a year.
โœ… NowIn two mouse models, the new engineered cells completely eliminated the tumours; human trials have not yet been reported.

In short

  • UC San Francisco scientists built B-SYNC CAR-T cells that stay inactive until they reach the brain.
  • In two mouse models, the cells completely eliminated diffuse midline glioma, a childhood brain cancer.
  • The cancer is almost always fatal within a year; the work is still in mice, not people.

Why it's good news

Diffuse midline glioma is aggressive and almost always fatal within a year, and few treatments reach it. This therapy is designed to stay inactive until it reaches the brain, which may limit effects elsewhere in the body. The results so far come from mice, so the next step is testing for safety and effect in people.

Advertisement

From ScienceDaily

Scientists at UC San Francisco have developed a powerful new cancer therapy that remains inactive until it reaches the brain, where it switches on to attack deadly tumors. The engineered immune cells, called B-SYNC CAR-T cells, completely eliminated diffuse midline glioma (DMG), an aggressive childhood brain cancer that is almost always fatal within a year, in two mouse models.

Read the full story at ScienceDaily Opens the publisher's site in a new tab.

Ask this story

An AI model answers from the material behind this story only, with a link to the source. Your question is sent to our AI provider and isn't stored. See Privacy.

More like this

Advertisement
AdMobile anchor